Yong-Bok Lee

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 31

Top Topics

Liquid Chromatography

Risk Assessment

Top Venues

Pharmacotherapy

Archives of toxicology

Biomedical chromatography : BMC

This page only lists publications with an associated author ORCID identifier.

Publications

Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Is Gender an Important Factor in the Precision Medicine Approach to Levocetirizine? Pharmaceutics 16 (1) (2024)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Is Gender an Important Factor in the Precision Medicine Approach to Levocetirizine? Pharmaceutics 16 (1) (2024)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Is Gender an Important Factor in the Precision Medicine Approach to Levocetirizine? Pharmaceutics 16 (1) (2024)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Population Pharmacokinetic Modeling of Zaltoprofen in Healthy Adults: Exploring the Dosage Regimen. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43 (2) (2023)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic-Pharmacodynamic Modeling. Biomedicines 11 (11) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43 (2) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43 (2) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy (2023)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling. Pharmaceutics 14 (12) (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling. Pharmaceutics 14 (12) (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling. Pharmaceutics 14 (12) (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Human risk assessment of 4-n-nonylphenol (4-n-NP) using physiologically based pharmacokinetic (PBPK) modeling: analysis of gender exposure differences and application to exposure analysis related to large exposure variability in population. Archives of toxicology 96 (10) (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. Journal of pharmaceutical investigation (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling. Pharmaceutics 14 (12) (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms. Pharmaceutics 14 (4) (2022)
Seung-Hyun Jeong, Ji-Hun Jang, Da-Hwa Jung, Guk-Yeo Lee, Yong-Bok Lee
Pharmacokinetic Changes According to Single or Multiple Oral Administrations of Socheongryong-Tang to Rats: Presented as a Typical Example of Changes in the Pharmacokinetics Following Multiple Exposures to Herbal Medicines. Pharmaceutics 13 (4) (2021)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Human risk assessment of di-isobutyl phthalate through the application of a developed physiologically based pharmacokinetic model of di-isobutyl phthalate and its major metabolite mono-isobutyl phthalate. Archives of toxicology 95 (7) (2021)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Pharmacokinetic Comparison between Methotrexate-Loaded Nanoparticles and Nanoemulsions as Hard- and Soft-Type Nanoformulations: A Population Pharmacokinetic Modeling Approach. Pharmaceutics 13 (7) (2021)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Toxicokinetics of di-isodecyl phthalate and its major metabolites in rats through the application of a developed and validated UHPLC-ESI-MS/MS method. Archives of toxicology 95 (11) (2021)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Population Pharmacokinetic Analysis of Cefaclor in Healthy Korean Subjects. Pharmaceutics 13 (5) (2021)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Pharmacokinetic Comparison of Epinastine Using Developed Human Plasma Assays. Molecules (Basel, Switzerland) 25 (1) (2020)
Yeon Kyung Nam, Seong Chul Jin, Woong Mo Yang, La Yoon Choi, Yong-Bok Lee, Woong Mo Yang
Banhahubak-Tang Tablet, a Standardized Medicine Attenuates Allergic Asthma via Inhibition of Janus Kinase 1 (JAK1)/ Signal Transducer and Activator of Transcription 6 (STAT6) Signal Pathway. Molecules (Basel, Switzerland) 25 (9) (2020)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Simultaneous determination of asarinin, β-eudesmol, and wogonin in rats using ultraperformance liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies following administration of standards and Gumiganghwal-tang. Biomedical chromatography : BMC 35 (4) (2020)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
Pharmacokinetic Comparison of Three Different Administration Routes for Topotecan Hydrochloride in Rats. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Seung-Hyun Jeong, Ji-Hun Jang, Hea-Young Cho, Yong-Bok Lee
Simultaneous measurement of epinastine and its metabolite, 9,13b-dehydroepinastine, in human plasma by a newly developed ultra-performance liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies. Biomedical chromatography : BMC 34 (9) (2020)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Enhanced Lymphatic Delivery of Methotrexate Using W/O/W Nanoemulsion: In Vitro Characterization and Pharmacokinetic Study. Pharmaceutics 12 (10) (2020)
Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee
A novel and sensitive UPLC-MS/MS method to determine mequitazine in rat plasma and urine: Validation and its application to pharmacokinetic studies. Biomedical chromatography : BMC 33 (10) (2019)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery. International journal of molecular sciences 20 (13) (2019)
Ji-Hun Jang, Seung-Hyun Jeong, Hea-Young Cho, Yong-Bok Lee
Population Pharmacokinetics of Cis-, Trans-, and Total Cefprozil in Healthy Male Koreans. Pharmaceutics 11 (10) (2019)